Key result
17 α-methyltestosterone lowers serum and α-lipoprotein cholesterol in dogs, unless supplemented with dietary cholesterol.
Answers are grounded in this paper and cite their sources.
It has been confirmed that the oral administration of 17 α-methyltestosterone lowers the serum cholesterol concentrations of dogs fed a stock diet containing 3 Gm. of fat and 22 mg. of cholesterol per 100 Gm. The elevated serum cholesterol levels of cholesterol-fed euthyroid dogs, and of hypothyroid dogs fed a high fat diet, were significantly lowered by the oral administration of 17 α-methyltestosterone. The hypocholesteremic effect of 17 α-methyltestosterone was also observed in dogs maintained on a high fat-low cholesterol diet, but not on the same high fat diet supplemented with 1.5 per cent cholesterol. When 17 α-methyltestosterone was given by intramuscular injection in the same dosage as used for oral administration, the hypocholesteremic effect was more rapid and pronounced than that seen following oral administration; 17 α-methyltestosterone consistently lowered the cholesterol content of the α-lipoprotein fraction. Its effect on the β-fraction depended upon the composition of the diet.
No takes yet. Share an insight, caveat, or question.
Abell et al. (1962) studied Hypercholesterolemia in dogs. 17 α-methyltestosterone (oral or intramuscular) vs. Oral vs intramuscular administration across varying dietary fat and cholesterol regimens was evaluated on Serum cholesterol concentration and lipoprotein fraction cholesterol content. Oral and intramuscular 17 α-methyltestosterone significantly lowered serum and α-lipoprotein cholesterol in dogs on stock or high-fat diets, except when supplemented with 1.5% cholesterol.
Synapse has enriched 10 related papers. Consider them for comparative context: